SMMT · Categories · Insider Buys
SMMT - Insider purchases
Summit Therapeutics Inc. (SMMT) insider purchases - real-time wire coverage filtered to Insider Buys only.
Recent Insider Buys for SMMT
- Co-Chief Executive Officer Zanganeh Mahkam bought $49,987,200 worth of shares (3,810,000 units at $13.12) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Co-Chief Executive Officer Duggan Robert W bought $49,987,200 worth of shares (3,810,000 units at $13.12), increasing direct ownership by 0.67% to 573,883,879 units (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Co-Chief Executive Officer Duggan Robert W bought $1,460,000 worth of shares (100,000 units at $14.60) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Co-Chief Executive Officer Zanganeh Mahkam bought $1,460,000 worth of shares (100,000 units at $14.60) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- COO and CFO Soni Manmeet Singh bought $722,250 worth of shares (50,000 units at $14.45), increasing direct ownership by 2% to 3,123,603 units (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Director Xia Yu bought $9,999,983 worth of shares (533,617 units at $18.74) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Co-Chief Executive Officer Duggan Robert W bought $499,983 worth of shares (26,680 units at $18.74) and was granted 14,247,597 shares, increasing direct ownership by 3% to 570,073,879 units (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Co-Chief Executive Officer Zanganeh Mahkam was granted 14,247,597 shares and bought $499,983 worth of shares (26,680 units at $18.74) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Co-Chief Executive Officer Zanganeh Mahkam bought $5,984,756 worth of shares (338,394 units at $17.69) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Co-Chief Executive Officer Duggan Robert W bought $5,984,756 worth of shares (338,394 units at $17.69), increasing direct ownership by 0.06% to 556,093,090 units (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Zanganeh Mahkam bought $411,094 worth of shares (110,321 units at $3.73), increasing direct ownership by 5% to 520,814 units (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Dhingra Ankur bought $375,000 worth of shares (100,000 units at $3.75) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Zanganeh Mahkam exercised 805,495 in-the-money shares at a strike of $1.49 and bought $10,350 worth of shares (5,000 units at $2.07) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Dhingra Ankur bought $44,254 worth of shares (20,400 units at $2.17) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)
- Soni Manmeet Singh bought $4,999,999 worth of shares (2,976,190 units at $1.68) (SEC Form 4)4 - Summit Therapeutics Inc. (0001599298) (Issuer)